Scarica l'app Stockscreener
2.79
2.11%
-0.06
Dopo l'orario di chiusura:
2.80
0.010
+0.36%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GDRX Giù?
Forum
Previsione
Precedente Chiudi:
$2.85
Aprire:
$2.85
Volume 24 ore:
1.68M
Relative Volume:
0.55
Capitalizzazione di mercato:
$947.02M
Reddito:
$775.09M
Utile/perdita netta:
$-58.68M
Rapporto P/E:
-21.04
EPS:
-0.1326
Flusso di cassa netto:
$64.06M
1 W Prestazione:
+2.95%
1M Prestazione:
+2.57%
6M Prestazione:
-42.36%
1 anno Prestazione:
-34.81%
Intervallo 1D:
$2.76
$2.85
Intervallo di 1 settimana:
$2.72
$2.92
Portata 52W:
$2.61
$5.8099
Goodrx Holdings Inc Stock (GDRX) Company Profile
Nome
Goodrx Holdings Inc
Settore
Industria
Telefono
(855) 268-2822
Indirizzo
2701 OLYMPIC BOULEVARD, SANTA MONICA
Confronta GDRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
2.79 | 967.38M | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
241.16 | 39.34B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 12.41B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
98.51 | 8.35B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
43.74 | 8.75B | 550.17M | 201.35M | 232.07M | 1.00 |
|
BTSG
Brightspring Health Services Inc
|
39.10 | 7.13B | 11.99B | 24.18M | 234.31M | 0.2956 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Underweight |
| 2025-08-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-08-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-10 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2023-07-31 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | Iniziato | Citigroup | Buy |
| 2022-11-04 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-12 | Iniziato | DA Davidson | Neutral |
| 2022-06-10 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-06 | Ripresa | BofA Securities | Buy |
| 2022-06-01 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-05-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Iniziato | Wells Fargo | Equal Weight |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-03-15 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | Reiterato | Barclays | Overweight |
| 2022-03-01 | Reiterato | BofA Securities | Neutral |
| 2022-03-01 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-03-01 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | Reiterato | Evercore ISI | Outperform |
| 2022-03-01 | Reiterato | Goldman | Buy |
| 2022-03-01 | Reiterato | JP Morgan | Underweight |
| 2022-03-01 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-03-01 | Reiterato | SVB Leerink | Outperform |
| 2022-01-07 | Iniziato | Goldman | Buy |
| 2021-12-21 | Iniziato | Stephens | Overweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-08-31 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-08-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-06 | Ripresa | Evercore ISI | Outperform |
| 2021-01-25 | Iniziato | Guggenheim | Buy |
| 2020-11-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | Iniziato | Barclays | Equal Weight |
| 2020-10-19 | Iniziato | BofA Securities | Neutral |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-19 | Iniziato | Cowen | Outperform |
| 2020-10-19 | Iniziato | Credit Suisse | Outperform |
| 2020-10-19 | Iniziato | Deutsche Bank | Hold |
| 2020-10-19 | Iniziato | Goldman | Neutral |
| 2020-10-19 | Iniziato | JP Morgan | Neutral |
| 2020-10-19 | Iniziato | Morgan Stanley | Overweight |
| 2020-10-19 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | Iniziato | SVB Leerink | Outperform |
| 2020-10-19 | Iniziato | UBS | Buy |
Mostra tutto
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
Can GoodRx Holdings Inc. stock deliver strong Q4 earningsJuly 2025 Opening Moves & Free Fast Entry Momentum Trade Alerts - ulpravda.ru
Is GoodRx Holdings Inc. stock positioned for digital transformationIPO Watch & Daily Profit Maximizing Trade Tips - ulpravda.ru
How supply chain issues affect GoodRx Holdings Inc. stockEarnings Beat & AI Powered Market Entry Ideas - ulpravda.ru
Can GoodRx Holdings Inc. stock surprise with earnings upsideJuly 2025 Spike Watch & Target Return Focused Picks - ulpravda.ru
Why GoodRx Holdings Inc. stock could outperform in 2025Trade Exit Summary & Accurate Technical Buy Alerts - ulpravda.ru
Is GoodRx Holdings Inc. stock a safe buy before earningsForecast Cut & High Conviction Buy Zone Alerts - ulpravda.ru
Scan a code at Giant Eagle to unlock cheaper Ozempic and Wegovy - Stock Titan
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring A 71.61% Upside Potential - DirectorsTalk Interviews
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost - Benzinga
GoodRx stock price target lowered to $2.60 at BofA on pharmacy headwinds - Investing.com UK
GoodRx Holdings Inc. (GDRX) PT Lowered to $2.60 at BofA Securities, Underperofrm, 'We Remain Cautious' - StreetInsider
New Wegovy weight-loss pill now $149 a month through GoodRx - Stock Titan
GoodRx stock price target lowered to $2.60 at BofA on pharmacy headwinds By Investing.com - Investing.com Nigeria
Preferred dividends of GoodRx Holdings, Inc. Class A – FWB:8GH - TradingView — Track All Markets
GoodRx Holdings And 2 Other Compelling Penny Stocks To Consider - Yahoo Finance
Morgan Stanley favors GoodRx (GDRX) and healthcare tech over managed care for 2026 citing strong market-beating potential - MSN
Morgan Stanley Favors GoodRx (GDRX) and Healthcare Tech Over Managed Care for 2026 Citing Strong Market-Beating Potential - Finviz
Aug Mood: Why GoodRx Holdings Inc. stock could outperform in 2025Trade Exit Report & Verified Chart Pattern Trade Signals - moha.gov.vn
Yakima Topic GOODRX HOLDINGS, INC. | News, Weather, Sports, Breaking News - KIMA
When Should You Buy GoodRx Holdings, Inc. (NASDAQ:GDRX)? - Yahoo Finance
GoodRx: The Tide Is Shifting Out Of This Company's Favor (Downgrade) (GDRX) - Seeking Alpha
Check out GoodRx Holdings's stock price (8GH-FF) in real time - CNBC
Can GoodRx Holdings Inc. stock attract ESG capital inflowsJuly 2025 Macro Moves & Community Trade Idea Sharing Platform - Улправда
What Wall Street predicts for GoodRx Holdings Inc. stock priceWeekly Stock Summary & Daily Risk Controlled Trade Plans - DonanımHaber
GoodRx Holdings (GDRX): Morgan Stanley Lowers Price Target to $4 - GuruFocus
Will GoodRx Holdings Inc. stock benefit from commodity pricesJuly 2025 Short Interest & Smart Allocation Stock Reports - Улправда
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com
Hims & Hers Scales Technology-Driven Care as Profitability Evolves - TradingView — Track All Markets
GoodRx approves retention bonuses for CEO and CFO - MSN
GoodRx Approves Retention Bonuses for CEO and CFO - The Globe and Mail
[8-K] GoodRx Holdings, Inc. Reports Material Event | GDRX SEC FilingForm 8-K - Stock Titan
Why GoodRx (GDRX) Stock Is Trading Lower Today - Finviz
Barclays Initiates Coverage of GoodRx Holdings (GDRX) with Underweight Recommendation - Nasdaq
Barclays Initiates Coverage on GoodRx Holdings (GDRX) with Under - GuruFocus
What Does Wall Street Think About GoodRx Holdings (GDRX)? - Insider Monkey
What does Wall Street think about GoodRx Holdings (GDRX)? - MSN
Officer Nabiey Acquires 7,983 Of GoodRx Holdings Inc [GDRX] - TradingView — Track All Markets
Is GoodRx Holdings Inc a good long term investmentRelative Strength Index (RSI) & Free Tremendous Growth Opportunities - earlytimes.in
9 Best Affordable Stocks Under $5 to Buy for the Next 3 Years - Insider Monkey
Will GoodRx Holdings Inc. stock outperform value stocksJuly 2025 Market Mood & Risk Managed Investment Strategies - Newser
Why The Narrative Around GoodRx Is Shifting Amid New Partnerships And Industry Uncertainty - Yahoo Finance
Declining Stock and Decent Financials: Is The Market Wrong About GoodRx Holdings, Inc. (NASDAQ:GDRX)? - 富途牛牛
Will GoodRx Holdings Inc. stock deliver long term returnsPortfolio Profit Report & Community Supported Trade Ideas - Newser
GoodRx Holdings (GDRX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
GoodRx Reaches $32 Million Settlement in Info Sharing Class Suit - Bloomberg Law News
XTX Topco Ltd Boosts Stake in GoodRx Holdings, Inc. $GDRX - MarketBeat
HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? - sharewise.com
Goodrx Holdings Inc Azioni (GDRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.50%
2.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):